A61K 35/768
Oncolytic viruses not provided for in groups a61k35/761 - a61k35/766
Official title: Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
A61K35/768 (Oncolytic viruses not provided for in groups a61k35/761 - a61k35/766) appears on 348 US grants and 747 published applications in this corpus.
Search patents in A61K- Granted patents
- 348
- Published applications
- 747
- Assignees
- 296
- Inventors
- 1,073
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 0 |
| 2002 | 2 | 6 |
| 2003 | 2 | 4 |
| 2004 | 1 | 6 |
| 2005 | 0 | 7 |
| 2006 | 4 | 12 |
| 2007 | 4 | 10 |
| 2008 | 3 | 14 |
| 2009 | 7 | 16 |
| 2010 | 7 | 17 |
| 2011 | 5 | 18 |
| 2012 | 10 | 18 |
| 2013 | 10 | 29 |
| 2014 | 15 | 23 |
| 2015 | 12 | 19 |
| 2016 | 12 | 27 |
| 2017 | 17 | 23 |
| 2018 | 17 | 34 |
| 2019 | 20 | 55 |
| 2020 | 25 | 65 |
| 2021 | 23 | 62 |
| 2022 | 31 | 81 |
| 2023 | 26 | 57 |
| 2024 | 25 | 60 |
| 2025 | 39 | 51 |
| 2026 | 29 | 33 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Oncolytic viruses encoding recombinant transforming growth factor (TGF)-beta monomers and uses thereof15 Sep 2026US 12,735,722 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Virus particles for therapeutic purposes18 Aug 2026US 12,708,654 B2Abalos Therapeutics GmbH
- Engineered adenovirus vectors and uses thereof18 Aug 2026US 12,709,761 B2
- Methods and compositions for improving oncolytic virus infection for nonpermissive cancers28 Jul 2026US 12,691,151 B2Arizona Board of Regents on behalf of Arizona State University
- Methods and materials for treating cancer8 Oct 2026US 2026/0306566 A1Mayo Foundation for Medical Education and Research
- Tumor neoantigen vaccine system specifically marking heterologous protein, and use thereof8 Oct 2026US 2026/0306620 A1China Pharmaceutical University
- Oncolytic virus therapy1 Oct 2026US 2026/0294987 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods for producing a super central memory cd8 t cell subtype by poly(adp-ribose) polymerase (parp) inhibition and uses thereof24 Sep 2026US 2026/0286302 A1Georgetown University
- Anticancer agent, pharmaceutical composition for cancer treatment, kit, and activator20 Aug 2026US 2026/0240929 A1BioComo Incorporation
Most cited
By later US patents
- Microorganisms for therapy104US 7,588,767 B2Genelux Corporation · 2009
- Microorganisms for therapy98US 7,754,221 B2Genelux Corporation · 2010
- Microorganisms for therapy85US 7,588,771 B2Genelux Corporation · 2009
- Microorganisms for therapy77US 7,662,398 B2Genelux Corporation · 2010
- Microorganisms for therapy58US 8,021,662 B2Genelux Corporation · 2011